4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Palatin Technologies, Inc. (PTN) operates in the Biotechnology industry and is headquartered in Princeton, United States with about 25 employees. Its market capitalization is roughly $9 million. In the fiscal year ended 2026-06-30, PTN reported $13M in revenue and ($8M) in net income.
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.
Interactive charts & full statements → Open the PTN valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Total Revenue | $13M | $13M | $0M | $4M | $5M | — |
| Gross Profit | — | — | $0M | $4M | $4M | $1M |
| Operating Income (EBIT) | ($9M) | ($9M) | ($18M) | ($22M) | ($32M) | — |
| Net Income | ($8M) | ($8M) | ($17M) | ($30M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $4M | $0M | $9M | $0M | — |
| Gross Profit | — | — | — | — | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($2M) | ($7M) | $5M | ($2M) | — |
| Net Income | ($4M) | ($1M) | ($7M) | $5M | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets | $8M | $3M | $11M | $18M | — |
| Total Liabilities | $2M | $8M | $11M | $20M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PTN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms